Published in Eur Radiol on August 06, 2009
Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology (2012) 2.14
Diagnostic accuracy of digital breast tomosynthesis versus digital mammography for benign and malignant lesions in breasts: a meta-analysis. Eur Radiol (2014) 2.10
Digital breast tomosynthesis is comparable to mammographic spot views for mass characterization. Radiology (2011) 1.31
High-resolution spiral CT of the breast at very low dose: concept and feasibility considerations. Eur Radiol (2011) 1.25
Digital breast tomosynthesis versus supplemental diagnostic mammographic views for evaluation of noncalcified breast lesions. Radiology (2012) 1.25
Prospective trial comparing full-field digital mammography (FFDM) versus combined FFDM and tomosynthesis in a population-based screening programme using independent double reading with arbitration. Eur Radiol (2013) 1.25
Breast tomosynthesis and digital mammography: a comparison of diagnostic accuracy. Br J Radiol (2012) 1.24
A review of breast tomosynthesis. Part II. Image reconstruction, processing and analysis, and advanced applications. Med Phys (2013) 1.14
Application of breast tomosynthesis in screening: incremental effect on mammography acquisition and reading time. Br J Radiol (2012) 1.12
Letter to the Editor re: Diagnostic accuracy of digital breast tomosynthesis versus digital mammography for benign and malignant lesions in breasts: a meta-analysis. Eur Radiol (2014) 1.07
Digital mammography imaging: breast tomosynthesis and advanced applications. Radiol Clin North Am (2010) 1.06
One-to-one comparison between digital spot compression view and digital breast tomosynthesis. Eur Radiol (2011) 1.05
Performance comparison of single-view digital breast tomosynthesis plus single-view digital mammography with two-view digital mammography. Eur Radiol (2012) 0.97
Image quality of microcalcifications in digital breast tomosynthesis: effects of projection-view distributions. Med Phys (2011) 0.96
Review of radiation dose estimates in digital breast tomosynthesis relative to those in two-view full-field digital mammography. Breast (2014) 0.95
Task-based strategy for optimized contrast enhanced breast imaging: analysis of six imaging techniques for mammography and tomosynthesis. Med Phys (2014) 0.94
Screening tests: a review with examples. Inhal Toxicol (2014) 0.94
Combination of one-view digital breast tomosynthesis with one-view digital mammography versus standard two-view digital mammography: per lesion analysis. Eur Radiol (2013) 0.93
Intensified surveillance for early detection of breast cancer in high-risk patients. Breast Care (Basel) (2015) 0.92
Breast mass characterization using 3-dimensional automated ultrasound as an adjunct to digital breast tomosynthesis: a pilot study. J Ultrasound Med (2013) 0.90
Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se. Geburtshilfe Frauenheilkd (2012) 0.89
Use of Tomosynthesis in Intraoperative Digital Specimen Radiography - Is a Reduction of Breast Re-excision Rates Possible? Geburtshilfe Frauenheilkd (2011) 0.86
Characterization of breast lesions: comparison of digital breast tomosynthesis and ultrasonography. Korean J Radiol (2015) 0.84
Digital tomosynthesis for PNS evaluation: comparisons of patient exposure and image quality with plain radiography. Korean J Radiol (2012) 0.84
Preliminary clinical experience with digital breast tomosynthesis in the visualization of breast microcalcifications. J Clin Imaging Sci (2013) 0.82
Full Field Digital Mammography (FFDM) versus CMOS Technology, Specimen Radiography System (SRS) and Tomosynthesis (DBT) - Which System Can Optimise Surgical Therapy? Geburtshilfe Frauenheilkd (2013) 0.81
Full Field Digital Mammography (FFDM) versus CMOS Technology versus Tomosynthesis (DBT) - Which System Increases the Quality of Intraoperative Imaging? Geburtshilfe Frauenheilkd (2012) 0.81
The adjunctive digital breast tomosynthesis in diagnosis of breast cancer. Biomed Res Int (2013) 0.81
Digital breast tomosynthesis versus mammography and breast ultrasound: a multireader performance study. Eur Radiol (2013) 0.80
X-ray phase-contrast imaging of the breast--advances towards clinical implementation. Br J Radiol (2014) 0.79
Digital Breast Tomosynthesis: State of the Art. Radiology (2015) 0.78
Effect of radiologists' experience on breast cancer detection and localization using digital breast tomosynthesis. Eur Radiol (2014) 0.77
Initial experience with combination digital breast tomosynthesis plus full field digital mammography or full field digital mammography alone in the screening environment. J Clin Imaging Sci (2014) 0.77
Addition of Digital Breast Tomosynthesis to Full-Field Digital Mammography in the Diagnostic Setting: Additional Value and Cancer Detectability. J Breast Cancer (2016) 0.76
Design and feasibility studies of a stationary digital breast tomosynthesis system. Nucl Instrum Methods Phys Res A (2011) 0.76
Characterization of lesions in dense breasts: Does tomosynthesis help? Indian J Radiol Imaging (2016) 0.75
Digital breast tomosynthesis within a symptomatic "one-stop breast clinic" for characterization of subtle findings. Br J Radiol (2015) 0.75
Reply to Letter to the Editor re: Diagnostic accuracy of digital breast tomosynthesis versus digital mammography for benign and malignant lesions in breasts: a meta-analysis. Eur Radiol (2014) 0.75
Visualization of Breast Microcalcifications on Digital Breast Tomosynthesis and 2-Dimensional Digital Mammography Using Specimens. Breast Cancer (Auckl) (2017) 0.75
Recall Rate Reduction with Tomosynthesis During Baseline Screening Examinations: An Assessment From a Prospective Trial. Acad Radiol (2015) 0.75
Breast MRI, digital mammography and breast tomosynthesis: comparison of three methods for early detection of breast cancer. Bosn J Basic Med Sci (2015) 0.75
"Staging of breast cancer and the advanced applications of digital mammogram: what the physician needs to know?" Br J Radiol (2017) 0.75
Comparison of visibility of circumscribed masses on Digital Breast Tomosynthesis (DBT) and 2D mammography: are circumscribed masses better visualized and assured of being benign on DBT? Eur Radiol (2016) 0.75
Characterization of Breast Masses in Digital Breast Tomosynthesis and Digital Mammograms: An Observer Performance Study. Acad Radiol (2017) 0.75
Quantitative contrast-enhanced spectral mammography based on photon-counting detectors: A feasibility study. Med Phys (2017) 0.75
Implementation and CT sampling characterization of a third-generation SPECT-CT system for dedicated breast imaging. J Med Imaging (Bellingham) (2017) 0.75
Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med (2005) 14.47
Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology (2002) 7.48
Digital tomosynthesis in breast imaging. Radiology (1997) 5.82
Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology (2008) 5.59
Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology (2004) 5.37
Digital breast tomosynthesis: initial experience in 98 women with abnormal digital screening mammography. AJR Am J Roentgenol (2007) 4.88
Glandular breast dose for monoenergetic and high-energy X-ray beams: Monte Carlo assessment. Radiology (1999) 2.98
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am (2003) 2.82
Current status of breast MR imaging. Part 2. Clinical applications. Radiology (2007) 2.65
Breast tomosynthesis and digital mammography: a comparison of breast cancer visibility and BIRADS classification in a population of cancers with subtle mammographic findings. Eur Radiol (2008) 2.22
Breast tomosynthesis: present considerations and future applications. Radiographics (2007) 1.70
Digital breast tomosynthesis: a pilot observer study. AJR Am J Roentgenol (2008) 1.69
Breast imaging reporting and data system (BI-RADS). Radiol Clin North Am (2002) 1.64
Initial clinical experience with contrast-enhanced digital breast tomosynthesis. Acad Radiol (2007) 1.46
Mammographically negative breast cancer at the Strathfield Breast Centre. Aust N Z J Surg (1996) 1.38
How reliable is modern breast imaging in differentiating benign from malignant breast lesions in the symptomatic population? Clin Radiol (1999) 1.17
Digital mammography: novel applications. Radiol Clin North Am (2007) 1.16
The additional diagnostic value of ultrasonography in the diagnosis of breast cancer. Arch Intern Med (2003) 1.06
Who should have breast magnetic resonance imaging evaluation? J Clin Oncol (2008) 1.04
A review of false negative mammography in a symptomatic population. Clin Radiol (1991) 1.02
The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers. Eur Radiol (2004) 0.93
Ultrasound is now better than mammography for the detection of invasive breast cancer. Am J Surg (2004) 0.92
BI-RADS decoded: detailed guidance on potentially confusing issues. Radiol Clin North Am (2007) 0.91
Advanced applications of digital mammography: tomosynthesis and contrast-enhanced digital mammography. Semin Roentgenol (2007) 0.87
Delayed diagnosis and large size of breast cancer after a false negative mammogram. Eur J Cancer (1994) 0.87
Analysis of patients with false negative mammography and symptomatic breast carcinoma. J Surg Oncol (2007) 0.85
Current applications and future direction of MR mammography. Br J Cancer (2003) 0.84
Reasons underlying negative mammography in patients with palpable breast cancer. Clin Radiol (1994) 0.82
Digital mammography: clinical implementation and clinical trials. Semin Roentgenol (2007) 0.78
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med (2004) 8.91
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol (2003) 7.57
Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med (2009) 5.36
8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol (2008) 3.94
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER). Lancet Oncol (2007) 3.32
High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. N Engl J Med (2003) 3.15
99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. J Nucl Med (2013) 2.37
Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients. Eur J Nucl Med Mol Imaging (2010) 2.32
Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg (2015) 2.30
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. J Clin Oncol (2005) 2.22
Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study. J Clin Oncol (2005) 2.14
Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients? J Urol (2012) 2.14
Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study. Lancet Oncol (2012) 2.12
Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla. Ann Surg Oncol (2013) 2.08
Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol (2010) 2.04
Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol (2006) 2.01
Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest (2005) 1.97
Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol (2006) 1.95
Volumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapy. Eur Radiol (2011) 1.89
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat (2009) 1.84
Repeatability of 18F-FDG uptake measurements in tumors: a metaanalysis. J Nucl Med (2012) 1.78
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat (2010) 1.75
Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol (2009) 1.74
Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study. Drugs Aging (2010) 1.69
Overall survival and PD-L1 expression in metastasized malignant melanoma. Cancer (2010) 1.68
Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2003) 1.67
Sleep endoscopy versus modified Mallampati score in sleep apnea and snoring. Laryngoscope (2005) 1.59
Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Ann Surg Oncol (2004) 1.59
Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. J Clin Oncol (2011) 1.59
Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat (2011) 1.55
Targeted vessel ablation for more efficient magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids. Cardiovasc Intervent Radiol (2011) 1.51
Prostate-sparing cystectomy: long-term oncological results. BJU Int (2009) 1.51
Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging (2014) 1.49
A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results. Breast Cancer Res Treat (2010) 1.47
Repeatability of metabolically active volume measurements with 18F-FDG and 18F-FLT PET in non-small cell lung cancer. J Nucl Med (2010) 1.47
Accuracy of internal mammary lymph node localization using lymphoscintigraphy, sonography and CT. Radiother Oncol (2002) 1.45
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. Cancer Immunol Immunother (2014) 1.42
Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment. Leuk Lymphoma (2011) 1.42
An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy. Urol Oncol (2011) 1.39
Individualization of therapy using Mammaprint: from development to the MINDACT Trial. Cancer Genomics Proteomics (2007) 1.38
Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis. Ann Surg Oncol (2013) 1.36
Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol (2004) 1.34
Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol (2013) 1.34
Tumor response and toxicity of neoadjuvant erlotinib in patients with early-stage non-small-cell lung cancer. J Clin Oncol (2012) 1.28
Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer. Radiother Oncol (2003) 1.28
The role of sleep position in obstructive sleep apnea syndrome. Eur Arch Otorhinolaryngol (2006) 1.25
Optimizing radiation treatment plans for lung cancer using lung perfusion information. Radiother Oncol (2002) 1.22
A novel, simplified ex vivo method for measuring water exchange performance of heat and moisture exchangers for tracheostomy application. Respir Care (2013) 1.22
Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke (2002) 1.21
Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results. AJR Am J Roentgenol (2008) 1.20
Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI. J Nucl Med (2010) 1.19
A self-assembled multimodal complex for combined pre- and intraoperative imaging of the sentinel lymph node. Nanotechnology (2010) 1.18
Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. Breast Cancer Res Treat (2006) 1.18
Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis. Eur J Cancer (2005) 1.18
Quantitative diffusion weighted imaging for differentiation of benign and malignant breast lesions: the influence of the choice of b-values. J Magn Reson Imaging (2010) 1.15
Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol (2007) 1.15
Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer (2006) 1.14
Is 18F-FDG PET/CT useful for the early prediction of histopathologic response to neoadjuvant erlotinib in patients with non-small cell lung cancer? J Nucl Med (2010) 1.13
Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study. Eur J Nucl Med Mol Imaging (2003) 1.13
Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization. PLoS One (2013) 1.12
Time trends in target volumes for stage I non-small-cell lung cancer after stereotactic radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.11
BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. J Clin Oncol (2010) 1.11
Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J Clin Oncol (2007) 1.10
TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation. J Immunol (2008) 1.08
Diffusion-weighted MRI of the liver for early tumor response assessment: Promising technique but evidence is still lacking. Acta Oncol (2010) 1.08
Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01. Eur J Cancer (2012) 1.07
Outcome after surgical resections of recurrent chest wall sarcomas. J Clin Oncol (2008) 1.06
Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer. Eur J Cancer (2010) 1.06
Incidence and risk factors of the intraoperative localization failure of nonpalpable breast lesions by radio-guided occult lesion localization: a retrospective analysis of 579 cases: reply. World J Surg (2013) 1.06
Radiofrequency ablation for treatment of sporadic angiomyolipoma. Urology (2008) 1.06
Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study. Eur J Cancer (2009) 1.05
Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys (2012) 1.04
Monitoring prostate thermal therapy with diffusion-weighted MRI. Magn Reson Med (2008) 1.04
MR-guided high-intensity focused ultrasound ablation of breast cancer with a dedicated breast platform. Cardiovasc Intervent Radiol (2012) 1.03
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy. Breast Cancer Res (2014) 1.03
Acceptance and long-term compliance of nCPAP in obstructive sleep apnea. Eur Arch Otorhinolaryngol (2007) 1.01
Radioactive seed localization of breast lesions: an adequate localization method without seed migration. Breast J (2011) 1.01
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques. Breast Cancer Res Treat (2011) 1.00
MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy. Ann Surg (2010) 0.99